|
Name |
10-epi-gamma-Eudesmol
|
| Molecular Formula | C15H26O | |
| IUPAC Name* |
2-[(2R,4aS)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1H-naphthalen-2-yl]propan-2-ol
|
|
| SMILES |
CC1=C2C[C@@H](CC[C@@]2(CCC1)C)C(C)(C)O
|
|
| InChI |
InChI=1S/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h12,16H,5-10H2,1-4H3/t12-,15+/m1/s1
|
|
| InChIKey |
WMOPMQRJLLIEJV-DOMZBBRYSA-N
|
|
| Synonyms |
10-epi-gamma-Eudesmol; epi-Eudesmol; 15051-81-7; 10-epi-eudesm-4-en-11-ol; 2-[(2R,4aS)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1H-naphthalen-2-yl]propan-2-ol; 2-((2R,4AS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-ol; 2-[(2R,4aS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl]propan-2-ol; epi-10- .gamma.-Eudesmol; SCHEMBL310948; CHEBI:62514; (-)-10-epi- .gamma.-eudesmol; ZINC15209455; AKOS032948531; (2R-trans)-1,2,3,4,4a,5,6,7-Octahydro-alpha,alpha,4a,8-tetramethyl-2-naphthalenemethanol; 2-Naphthalenemethanol, 1,2,3,4,4a,5,6,7-octahydro-alpha,alpha,4a,8-tetramethyl-, (2R-trans)-; C19893; Q27131975
|
|
| CAS | 15051-81-7 | |
| PubChem CID | 6430754 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 222.37 | ALogp: | 3.4 |
| HBD: | 1 | HBA: | 1 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 20.2 | Aromatic Rings: | 2 |
| Heavy Atoms: | 16 | QED Weighted: | 0.639 |
| Caco-2 Permeability: | -4.592 | MDCK Permeability: | 0.00001420 |
| Pgp-inhibitor: | 0.032 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.783 |
| 30% Bioavailability (F30%): | 0.037 |
| Blood-Brain-Barrier Penetration (BBB): | 0.209 | Plasma Protein Binding (PPB): | 94.08% |
| Volume Distribution (VD): | 1.5 | Fu: | 2.98% |
| CYP1A2-inhibitor: | 0.107 | CYP1A2-substrate: | 0.32 |
| CYP2C19-inhibitor: | 0.126 | CYP2C19-substrate: | 0.905 |
| CYP2C9-inhibitor: | 0.176 | CYP2C9-substrate: | 0.22 |
| CYP2D6-inhibitor: | 0.057 | CYP2D6-substrate: | 0.079 |
| CYP3A4-inhibitor: | 0.183 | CYP3A4-substrate: | 0.331 |
| Clearance (CL): | 10.989 | Half-life (T1/2): | 0.174 |
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.317 |
| Drug-inuced Liver Injury (DILI): | 0.035 | AMES Toxicity: | 0.003 |
| Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.176 |
| Skin Sensitization: | 0.392 | Carcinogencity: | 0.271 |
| Eye Corrosion: | 0.861 | Eye Irritation: | 0.887 |
| Respiratory Toxicity: | 0.94 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002195 | ![]() |
0.660 | D07QKN | ![]() |
0.415 | ||
| ENC002420 | ![]() |
0.387 | D02VPX | ![]() |
0.268 | ||
| ENC001013 | ![]() |
0.387 | D05BTM | ![]() |
0.263 | ||
| ENC002249 | ![]() |
0.375 | D0T2PL | ![]() |
0.263 | ||
| ENC002097 | ![]() |
0.365 | D0N1TP | ![]() |
0.263 | ||
| ENC000511 | ![]() |
0.358 | D02ZGI | ![]() |
0.263 | ||
| ENC004619 | ![]() |
0.354 | D0S7WX | ![]() |
0.235 | ||
| ENC000860 | ![]() |
0.348 | D04GJN | ![]() |
0.233 | ||
| ENC002989 | ![]() |
0.333 | D0K0EK | ![]() |
0.229 | ||
| ENC002248 | ![]() |
0.333 | D0G3PI | ![]() |
0.229 | ||